0.07Open0.07Pre Close0 Volume14 Open Interest35.00Strike Price0.00Turnover354.58%IV306.37%PremiumOct 18, 2024Expiry Date0.00Intrinsic Value100Multiplier13DDays to Expiry0.07Extrinsic Value100Contract SizeAmericanOptions Type0.0379Delta0.0144Gamma123.29Leverage Ratio-0.0173Theta0.0001Rho4.68Eff Leverage0.0013Vega
EyePoint Pharmaceuticals Stock Discussion
NEWS
EyePoint Pharmaceuticals Trial of Duravyu in Diabetic Eye Disease Fails to Meet Primary Endpoint
Larger Image: tradingview.com...
$EyePoint Pharmaceuticals (EYPT.US)$
$EyePoint Pharmaceuticals (EYPT.US)$
$Adverum Biotechnologies (ADVM.US)$
$Regenxbio (RGNX.US)$
$4D Molecular Therapeutics (FDMT.US)$
$Kodiak Sciences (KOD.US)$
📊⚡️📊
No comment yet